Dedicated and innovative Cancer Biology Scientist with experience in the biotechnology industry, currently advancing research at Ideaya Biosciences. Proven expertise in cancer research. Adept at designing and executing complex experiments, with a strong publication record and numerous awards for scientific presentations. Proficient in cutting-edge techniques including CRISPR, immunoanalysis, and animal modeling. Demonstrated leadership in collaborative research projects and a keen ability to translate scientific findings into therapeutic strategies. Committed to driving innovative solutions in oncology to improve patient outcomes.
Supervisor: Antonis E. Koromilas
Field of research: The adaptive trait of the integrate stress response promotes KRAS lung cancer
Supervisor: Dr. Brandon Findlay
Field of research: understanding the evolutionary dynamics of antibiotic resistance in bacteria, specifically Escherichia coli, when exposed to antibiotic gradients in a soft agar environment.
Courses: CHEM 205 (General Chemistry 1), CHEM 222 (Introductory Organic Chemistry 2), CHEM 375 (Introductory Biochemistry 2)
Supervisors:
Dr. Cerrie Rogers - cerrie.rogers@concordia.ca
Zornitsa Stoyanova - zornitsa.stoyanova@concordia.ca
Dr. Neema Chirwa - neema.chirwa@concordia.ca
Technical skills
Spoken Languages
Computer skills
Public Speaking
Hobbies and interests:
Publications
Conference Presentations
Ghaddar N, Wang S, Woodvine B, Krishnamoorthy J, Darini C, Van Hoef V, Kazimierczak U, Ah-son N, Officer L, Teodosio A, Popper H, Broggini M, Mann K, Hatzoglou M, Topisirovic I, Larsson O, Le Quesne J, Koromilas AE. The Integrated Stress Response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer.
Ghaddar N, Findlay B. Developing Antimicrobial Resistance in Bacteria Via a Bacterial Evolution Chamber.
Awards